Programme SOM0044 for Parkinson’s Disease
SOM0044 is a small molecule for the treatment of Parkinson’s disease.
Trodelvy (sacituzumab govitecan) for the Treatment of Advanced Triple-Negative Breast Cancer
Trodelvy is a Trop-2-directed antibody and topoisomerase inhibitor conjugate. Credit: Alexkich/Shutterstock.
Learn more
Hover over the logos to learn more about the companies who made this project possible.
Close
-
Pilloxa
Pilloxa creates digital and remote solutions to optimise clinical trials...
About
Pilloxa creates digital and remote solutions to optimise clinical trials and patient support programmes through supporting medical adherence and patient retention.
FollowMake an Enquiry
-
KPS
Founded in 2010, KPS is a Functional Service Provider (FSP)...
About
Founded in 2010, KPS is a Functional Service Provider (FSP) offering Clinical Monitoring, Project Management and CRO Oversight solutions to the biopharmaceutical industry.
FollowMake an Enquiry
-
SOM Biotech
SOM Biotech is an Artificial Intelligence AI drug discovery and...
About
SOM Biotech is an Artificial Intelligence AI drug discovery and development company focused on the development of therapies for orphan indications through the proprietary AI-based drug discovery technology.
FollowMake an Enquiry